Follow
Lawrence Kwong
Lawrence Kwong
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
19492015
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
14012018
Loss of PTEN promotes resistance to T cell–mediated immunotherapy
W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ...
Cancer discovery 6 (2), 202-216, 2016
10412016
Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade
PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ...
Cancer discovery 6 (8), 827-837, 2016
7022016
Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles
F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ...
Cell reports 18 (11), 2780-2794, 2017
4282017
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma
LN Kwong, JC Costello, H Liu, S Jiang, TL Helms, AE Langsdorf, ...
Nature medicine 18 (10), 1503-1510, 2012
3452012
Passenger deletions generate therapeutic vulnerabilities in cancer
FL Muller, S Colla, E Aquilanti, VE Manzo, G Genovese, J Lee, ...
Nature 488 (7411), 337-342, 2012
2992012
APC and Its Modifiers in Colon Cancer
LN Kwong, WF Dove
Apc Proteins, 85-106, 2009
2542009
Integrative genome comparison of primary and metastatic melanomas
O Kabbarah, C Nogueira, B Feng, RM Nazarian, M Bosenberg, M Wu, ...
PloS one 5 (5), e10770, 2010
2172010
Systematic identification of signaling pathways with potential to confer anticancer drug resistance
CA Martz, KA Ottina, KR Singleton, JS Jasper, SE Wardell, ...
Science signaling 7 (357), ra121-ra121, 2014
1772014
Non-germline genetically engineered mouse models for translational cancer research
J Heyer, LN Kwong, SW Lowe, L Chin
Nature Reviews Cancer 10 (7), 470-480, 2010
1752010
A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer
JM Amos-Landgraf, LN Kwong, CM Kendziorski, M Reichelderfer, ...
Proceedings of the National Academy of Sciences 104 (10), 4036-4041, 2007
1642007
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
AT Boutin, WT Liao, M Wang, SS Hwang, TV Karpinets, H Cheung, ...
Genes & development 31 (4), 370-382, 2017
1212017
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma
G Genovese, A Ergun, SA Shukla, B Campos, J Hanna, P Ghosh, ...
Cancer discovery 2 (8), 736-749, 2012
1162012
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
LN Kwong, GM Boland, DT Frederick, TL Helms, AT Akid, JP Miller, ...
The Journal of clinical investigation 125 (4), 1459-1470, 2015
1092015
Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models
MS Lee, TL Helms, N Feng, J Gay, QE Chang, F Tian, JY Wu, C Toniatti, ...
Oncotarget 7 (26), 39595, 2016
1052016
Navigating the therapeutic complexity of PI3K pathway inhibition in melanoma
LN Kwong, MA Davies
Clinical Cancer Research 19 (19), 5310-5319, 2013
972013
Targeted therapy for melanoma: rational combinatorial approaches
LN Kwong, MA Davies
Oncogene 33 (1), 1-9, 2014
912014
A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily
A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ...
Cell systems 7 (4), 422-437. e7, 2018
892018
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
G Genovese, A Carugo, J Tepper, FS Robinson, L Li, M Svelto, L Nezi, ...
Nature 542 (7641), 362-366, 2017
862017
The system can't perform the operation now. Try again later.
Articles 1–20